BillionToOne, Inc. (BLLN) stock

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30

$105.15−5.64 (-5.09%)

Close on Nov 13, 2026Market cap $4.96BP/E –Yield –

BillionToOne enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

BillionToOne's enterprise value was $3.93B on Nov 11, 2026, against $1.26B a year earlier.

Period	Period end	Value	Change
2026	Nov 11, 2026	$3.93B	+446.5%
2025	Dec 31, 2025	$719.69M	–

Parsed from the XBRL in BillionToOne's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BLLN.

Revenue growth71.9% · median 17.5%

Gross margin71.4% · median 74.5%

Operating margin10.2% · median 4.8%

Net margin11.3% · median 7.9%

Advertisement
300 × 250

See a number that looks wrong?